The bear market of 2022 was especially unkind to many cloud software stocks, but things started to look up for some of them in 2023. As measured by the First Trust Cloud Computing ETF, the cloud software stock sector is up over 30% through the first nine months of 2023. Alteryx (NYSE: AYX) got some bullish sentiment in the last month, including an analyst upgrade.
Citizens JMP director of financial technology research Devin Ryan joins Market Domination to discuss his top crypto and fintech plays and the sectors' outlook as the election looms ahead. Ryan points to Robinhood (HOOD) as a buying opportunity despite it trading at 11 times its 2025 EBITDA (earnings before interest, taxes, depreciation, and amortization) estimate. "You can make an argument that there's still a long way to go," Ryan says, pointing to the fact that, he says, the company has grown its revenues by 40% this year and made more money in the first half of 2024 than they did in all of 2023 all while keeping expenses low. He also sees Goldman Sachs (GS) as a good opportunity, noting that it is a "pure play on a capital markets recovery." He explains, "We've been in this incredibly depressed capital markets environment the last two and a half years... So if you think we're going to recover there, which lower interest rates, more risk-on, and just purely time going by, Goldman is going to be more levered to that." However, he notes that Morgan Stanley (MS) is in a weaker position despite it being a "stable" company. Ryan argues "wealth management has benefited from higher interest rates. As rates come down, you get a little bit of a headwind from interest rates. So what's been a benefit becomes a little bit of a headwind. And so they're less of a pure play on that capital markets story." As the presidential election lies less than two months away, Ryan explains that the Trump campaign is running on less regulation than the Harris campaign, making it a "friendlier administration for fintech, for crypto." He adds, "The voting bloc is becoming much more pro-crypto, there's more people that have exposure to crypto in the United States." Thus, single-issue voters are going to be very important in this upcoming election. He believes that because of this the Harris administration will likely roll out "more constructive" policy than the Biden administration has over the last four years. "That doesn't necessarily mean everything's going to be great, that the industry wants. But I think we're moving the pendulum more toward the middle," he concludes. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Melanie Riehl
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Asante Gold Corporation (CSE: ASE | GSE: ASG | FRANKFURT:1A9 | U.S.OTC: ASGOF) (“Asante” or the "Company") is pleased to announce that it has received approval from the Securities and Exchange Commission of Ghana and the Ghana Stock Exchange (collectively, the “Ghana Regulatory Authorities”) for the filing of a base shelf prospectus (the “Base Shel
LONDON, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, announced the appointment of Matthias Will, M.D., as Chief Development Officer. Dr. Will is joining Autolus’ executive team and will lead the company's development organization effective September 30, 2024. “Matthias has a proven track record of success in pharmaceutical product development, achieving many key regul
MONTREAL, Sept. 19, 2024 (GLOBE NEWSWIRE) -- PyroGenesis Canada Inc. (“PyroGenesis”) (http://pyrogenesis.com) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY), a high-tech company that designs, develops, manufactures and commercializes advanced plasma processes and sustainable solutions which are geared to reduce greenhouse gases (GHG) and address environmental pollutants, is pleased to congratulate its client EarthGrid, which announced yesterday that it has signed a joint venture agreement with EnerTech, a
ONTARIO, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Heritage Grocers Group (“Heritage” or “HGG”), one of the leading Hispanic food retailers in the country, is pleased to announce its portfolio of companies that includes Cardenas Markets, El Rancho Supermercado and Tony’s Fresh Market has officially kicked off a series of initiatives to celebrate Hispanic Heritage Month, which takes place now through October 15. Each Heritage banner company continues to honor Hispanic heritage and will hold vari
NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Slam Corp. (OTCQX: SLAMF), a special purpose acquisition company led by World Series Champion Alex Rodriguez, has qualified to trade on the OTCQX® Best Market. Slam Corp. previously traded its Class A ordinary shares, par value $0.0001 per share (the “Class A Ordinary Shares”), units, each consisting of one Ordinary
NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announced the National Institutes of Health (NIH), National Institute on Aging have awarded a $4 Million grant to Dr. Howard Weiner as principal investigator at Brigham and Women’s Hospital to be t
NAPLES, Fla., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Beasley Broadcast Group Inc. (Nasdaq: BBGI), a multi-platform media company (the “Company”), today announced that its Board of Directors (the “Board”) has approved a reverse stock split of its Class A Common Stock and Class B Common Stock (collectively, the “Common Stock”) at a ratio of 1-for-20. Stockholders previously approved the reverse stock split on August 26, 2024 and provided the Board with discretion to determine the final reverse stock s
VANCOUVER, British Columbia, Sept. 19, 2024 (GLOBE NEWSWIRE) -- ValOre Metals Corp. (“ValOre”; TSX‐V: VO; OTCQB: KVLQF; Frankfurt: KEQ0, “the Company”) today announced a partnership with VRIFY which incorporates VRIFY’s cutting-edge Artificial Intelligence (“AI”) mineral targeting platform. This partnership aims to both accelerate and enhance the mineral discovery process by taking an unbiased data-driven approach combined with traditional geoscience methods to quickly identify areas with the hi
LOS ANGELES, Sept. 19, 2024 (GLOBE NEWSWIRE) -- ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in immunology, today announced that positive results from the company’s global Phase 3 clinical trial of izokibep in moderate-to-severe hidradenitis suppurativa (HS) patients will be shared as a late-breaking oral presentation at the 2024 European Academy of Dermatology and Venereology taking place
Katy, Texas, Sept. 19, 2024 (GLOBE NEWSWIRE) -- CW Petroleum Corp (OTCQB: CWPE) (the “Company”), a leading provider of Specialty Renewable and Hydrocarbon Motor Fuels, today announces to its investors and future investors it has had numerous discussions with OTC Markets regarding Yahoo Finance and Apple Stocks App powered by Yahoo Finance for providing inaccurate daily trade data and price settlements. As of September 19, 2024, OTC Markets has not provided CW Petroleum Corp with a resolution reg
BETHESDA, Md., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced presentations, including two late-breakers, at Neuroscience 2024 featuring preclinical data supporting development of GT-02287, the Company’s clinical stage lead drug candidate, in Parkinson’s disease with or without a GBA1 mut
Press Release Dr. Paulo Fontoura, MD, PhD, joins STALICLA as Chief Scientific and Clinical Development Advisor Geneva, Switzerland – September 19, 2024 – STALICLA SA, a Swiss neuro precision biotech company dedicated to developing precision medicine-based treatments for neurodevelopmental disorders, announced today that Dr. Paulo Fontoura will be joining their drug development team as Chief Scientific and Clinical Development Advisor. Dr. Fontoura will work to support STALICLA’s mission to trans
–Achilles to discontinue development of TIL-based cNeT therapy– –Cash position of $95.1 million as of June 30, 2024– –BofA Securities engaged to provide strategic financial advice– LONDON, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL) today announced the discontinuation of its TIL-based cNeT program and closure of the Phase I/IIa CHIRON and THETIS clinical trials. The Company will refocus its strategy to explore further engagement with third parties who are developi
BETHESDA, Md., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Today, the Addiction Policy Forum released new fentanyl awareness resources available in 12 languages to help increase knowledge of fentanyl-related overdose risks. The project is supported by the Cencora Impact Foundation and the Ethnic Communities Opioids Response Network – Missouri (ECORN-MO) to provide open-source, science-backed prevention materials for communities and families with limited English proficiency. Recent reports from the Center
SHOHAM, Israel, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Mobilicom Limited (Nasdaq: MOB), a provider of cybersecurity and robust solutions for drones and robotics, is pleased to invite investors to a webinar on September 25, 2024, at 4:15 p.m. ET. The exclusive event, hosted by RedChip Companies, will feature Mobilicom Founder and CEO Oren Elkayam, who will share insight into the company’s recent successes and near-term growth initiatives, as well as its comprehensive and proprietary technology suite.
Solid board market poised for sustained growth momentum, driven by increasing demand and expansion.Rockville, MD , Sept. 19, 2024 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global Solid Board Market is estimated to reach a valuation of US$ 10.0 billion in 2024 and is expected to grow at a CAGR of 2.8% during the forecast period of (2024 to 2034). Solid board has been used since its inception as the best packing material for production.
Nayax is proud to be a sponsor of Feeding the Future’s Golf Classic for the fourth consecutive yearHERZLIYA, Israel, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX), a global commerce enablement payments and loyalty platform designed to help merchants scale their business, today announced that it will sponsor Five Star's 2024 Feeding the Future Golf Classic in Chattanooga, Tennessee on September 23, 2024. Founded in 2017 by Chattanooga-based Five Star Breaktime Solutions
HIGHLIGHTS: ATHA Energy has expanded its land package at the Angilak Project, acquiring the entire prospective Lac 50 structural corridor and an additional prospective parallel corridor. Both prospective corridors are related to the Snowbird Tectonic Zone, a deep crustal structure that extends from the Athabasca Basin, host to some of the largest and highest-grade uranium deposits globally, through to the Angikuni Basin, which hosts the Lac 50 Uranium Deposit.The Company has staked an additional
BALA CYNWYD, Pa., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that data from the Company’s nomlabofusp Phase 1 studies and Phase 2 dose exploration study, some of which has been previously disclosed, will be presented at the annual International Congress for Ataxia Research (ICAR) being held November 12-15, 2024 in London, U.K. Nomlabofusp
Yahoo Finance